-
Letting children catch Covid may be safer than giving them vaccine, say experts
firstwordpharma
July 01, 2021
A member of the UK's Joint Committee on Vaccination and Immunisation (JCVI) says allowing children to catch COVID-19 may be better than exposing them to the "risk" of vaccines, reported The Telegraph.
-
Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine
firstwordpharma
July 01, 2021
Novavax today announced the publication of results from the final analysis of a pivotal Phase 3 clinical trial of its COVID-19 vaccine candidate conducted in the United Kingdom in the New England Journal of Medicine (NEJM).
-
Fujifilm Diosynth Biotechnologies to expand biologics manufacturing capacity
cphi-online
July 01, 2021
As part of $850 million investment package, CDMO will double US cell culture production for recombinant vaccines and increase UK gene therapy production tenfold.
-
AHA News: Embraceable, Healthy News: Hugging Is Back
drugs
June 30, 2021
After a year of being COVID-cautious, Linda Matisoff counted the days until she could hug her 5-year-old granddaughter, Laila, again.
-
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
firstwordpharma
June 30, 2021
Healthcare professionals including infectious disease physicians, family physicians, emergency room physicians, hematologists, neurologists, pharmacists, public health officials, nurses and nurse practitioners, and healthcare professionals at identified p
-
RDIF: Sputnik V has demonstrated 97.8% efficacy against COVID cases and 100% efficacy against severe cases of COVID in UAE
prnewswire
June 30, 2021
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the data of UAE's Ministry of Health on the Russian Sputnik V coronavirus vaccine confirming its safety and high efficacy during the vaccination campaign.
-
Seven Cases of Guillain-Barré Noted After COVID-19 Vaccine in India
drugs
June 29, 2021
Cases of Guillain-Barré syndrome (GBS) have been reported after receipt of the Oxford-AstraZeneca severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, according to two reports published online June 10 in the Annals of Neurology.
-
Analysis shows stronger immunity by delaying AstraZeneca COVID-19 vaccine doses
firstwordpharma
June 29, 2021
A sub-analysis from two studies indicates that a long interval between the first and second doses of AstraZeneca's COVID-19 vaccine Vaxzevria does not compromise immune response after a late second dose, while a third dose continues to boost antibodies.
-
Is the ‘Delta Plus’ COVID-19 Variant a New Concern?
drugs
June 28, 2021
India, already hit hard by the Delta variant of COVID-19, has labeled a closely related new variant -- dubbed "Delta Plus" -- as a "variant of concern."
-
Test batch of the Sputnik V vaccine produced in Iran
firstwordpharma
June 28, 2021
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Actoverco, one of Iran’s leading pharmaceutical companies, announce the production of a test batch of the Russian Sputnik V vaccine against coronavirus.